Retinal microstructure in patients with EFEMP1 retinal dystrophy evaluated by Fourier domain OCT

Eye

Volumn 23, Issue 2, 2009, Pages 480-483

  Gerth, C ^a,b   Zawadzki, R J ^c   Werner, J S ^c   Heon E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autosomal dominant drusen; EFEMP1; Fourier domain OCT; Malattia leventinese

Indexed keywords

VISUAL PIGMENT; EFEMP1 PROTEIN, HUMAN; SCLEROPROTEIN;

ADULT; ARTICLE; BRUCH MEMBRANE; CASE REPORT; EFEMP1 GENE; ELECTRORETINOGRAM; FEMALE; GENE; GENE MUTATION; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA DYSTROPHY; VISION; ELECTRORETINOGRAPHY; EYE DISEASE; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; RETINA DEGENERATION; VISUAL ACUITY;

ADULT; BRUCH MEMBRANE; ELECTRORETINOGRAPHY; EXTRACELLULAR MATRIX PROTEINS; EYE DISEASES, HEREDITARY; HUMANS; MALE; MIDDLE AGED; MUTATION; RETINA; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 60149098424     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.251     Document Type: Article

References (12)

1. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999; 22(2): 199-202.
2. Michaelides M, Jenkins SA, Brantley Jr MA, Andrews RM, Waseem N, Luong V et al. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Invest Ophthalmol Vis Sci 2006; 47(7): 3085-3097.
3. Fu L, Garland D, Yang Z, Shukla D, Rajendran A, Pearson E et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 2007; 16(20): 2411-2422.
4. Gaillard MC, Wolfensberger TJ, Uffer S, Mantel I, Pournaras JA, Schorderet DF et al. [Optical coherence tomography in Malattia Leventinese]. Klin Monatsbl Augenheilkd 2005; 222(3): 180-185.
5. Souied EH, Leveziel N, Letien V, Darmon J, Coscas G, Soubrane G. Optical coherent tomography features of malattia leventinese. Am J Ophthalmol 2006; 141(2): 404-407.
6. Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update). Doc Ophthalmol 2004; 108(2): 107-114.
7. Wojtkowski M, Leitgeb R, Kowalczyk A, Bajraszewski T, Fercher AF. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt 2002; 7(3): 457-463.
8. Zawadzki RJ, Jones SM, Olivier SS, Zhao M, Bower BA, Izatt JA et al. Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in-vivo imaging. Opt Express 2005; 13(21): 8532-8546.
9. Zawadzki RJ, Fuller AR, Wiley DF, Hamann B, Choi SS, Werner JS. Adaptation of a support vector machine algorithm for segmentation and visualization of retinal structures in volumetric optical coherence tomography data sets. J Biomed Opt 2007; 12(4): 041206.
10. Collins ET. A pathological report upon a case of Doyne's chorioditis ('Honeycomb' or 'family' choroiditis). The ophthalmoscope 1913; 11: 537-538.
11. Dusek J, Streicher T, Schmidt K. Hereditary drusen of Bruch's membrane. II: studies of semi-thin sections and electron microscopy results. Klin Monatsbl Augenheilkd 1982; 181(2): 79-83.
12. Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum Mol Genet 2007; 16(20): 2423-2432.